| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |